news

BioDuro-Sundia Announces New CEO

BioDuro-Sundia names Haijun Dong, PhD, MBA as new CEO. With deep expertise in drug discovery and development, he leads global growth and operational excellence
February 09, 2021

BioDuro-Sundia received the “2020 EXCELLENT Team Service” award from Lynk Pharmaceuticals

We received the “2020 EXCELLENT Team Service” award from Lynk Pharmaceuticals, as recognition of the efforts and contributions made by the drug discovery...
January 18, 2021

Congratulations to DartsBio Pharmaceutical for Analgesic DS002 Injection Approved for Clinical Trial by NMPA

BioDuro Expands Manufacturing Capabilities in China and the US, Enhancing Integrated Drug Development Services Globally. Your trused CRDMO. Moving you Forward
December 25, 2020

Congratulations To GenFleet Therapeutics For Selective CDK9 Inhibitor GFH009 Injection Approved For Clinical Trial by NMPA

CDK9 inhibitor GFH009 Injection has been approved by the CDE (Center for Drug Evaluation), NMPA for clinical trials | BioDuro-Sundia | Moving You Forward
December 21, 2020

BioDuro & Silexon Form Strategic Collaboration to Develop New Anti-Cancer Drugs

BioDuro and Silexon collaborate on new anti-cancer drugs, leveraging advanced NASH models for accelerated preclinical testing and development | BioDuro-Sundia
December 03, 2020

Congratulations! Innocare‘s Orelabrutinib has been approved by NMPA for Commercial in China!

InnoCare Pharma's BTK inhibitor, Orelabrutinib, receives NMPA approval for commercialization in China, targeting mantle cell lymphoma and chronic lymphocytic ...
November 22, 2020

Congratulations to TaiGen’s Flu Antiviral Drug TG-1000 for Receiving FDA approval of IND

TaiGen Biotechnology has received FDA approval for the clinical trial application of their new influenza antiviral drug, TG-1000, targeting influenza A and B.
November 02, 2020

Congratulations to Longwood Biopharmaceuticals for LW402 Accepted for Clinical Trial

BioDuro-Sundia assists Longwood Biopharmaceuticals to complete the API production research of LW402 tablets | For the treatment of Rheumatoid Arthritis.
September 26, 2020
Total 93 12345678...1112
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all